HIV :: Two HIV positive boys expelled from Indian orphanage
Two HIV-positive boys have been forced to leave an orphanage in India’s Gujarat state after staff said they posed an unacceptable risk to the safety of other children, an official said.
Health
Flu :: Israel resumed flu vaccinations – Health Minister Yaacov Ben-Yizri
Israel resumed flu vaccinations on Monday after the Health Ministry determined that the deaths of four men who had been inoculated in the past week were not linked to the vaccine.
Fertility :: Increased risk of infertility on using mobile phones
Men who use mobile phones could be risking their fertility, warn researchers. A new study shows a worrying link between poor sperm and the number of hours a day that a man uses his mobile phone. Those who made calls on a mobile phone for more than four hours a day had the worst sperm counts and the poorest quality sperm, according to results released at the American Society for Reproductive Medicine annual meeting in New Orleans. Doctors believe the damage could be caused by the electromagnetic radiation emitted by handsets or the heat they generate.
Diabetes :: Updates on Counterfeit Blood Glucose Test Strips for LifeScan
On October 13, 2006, the U.S. Food and Drug Administration (FDA) alerted the public to counterfeit blood glucose test strips being sold in the United States for use with various models of LifeScan, Inc., One Touch Brand Blood Glucose Monitors. These test strips are used by people with diabetes to measure their blood glucose. Today’s announcement provides two additional lot numbers that are included in the distribution of counterfeit products, along with descriptions of how to identify them.
Allergy :: Altana’s Omnaris, ciclesonide nasal spray for allergies, allergic rhinitis, hay fever
The Food and Drug Administration (FDA) announced the approval of Omnaris (ciclesonide) nasal spray, a new drug for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis, commonly known as hay fever, in adults and children 12 years of age and older.
Health :: Smarter working and improved productivity
Tackling wide variation could deliver benefits for patient care and better value for money. Improved NHS productivity and better efficiency could unlock resources worth ?2.2bn for the NHS and improve patient care at the same time, Health Minister Andy Burnham said today.
Health :: Learning Katrina?s Lesson – serve the vulnerable in emergencies
On Tuesday and Wednesday of this week, over 150 community leaders and human service providers will come together to strengthen how vulnerable residents are readied for and helped during a disaster. Katrina?s Lesson: Reach Our Vulnerable Residents NOW is one of the first conferences of its kind in King County to unite private and public agencies in this effort.
Imaging :: Philips streamlines cath lab care and management
Royal Philips (NYSE: PHG, AEX: PHI) will showcase innovative cardiac solutions designed to streamline workflow and facilitate advanced information management at Cardiovascular Research Foundation?s (CRF) eighteenth annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in Washington, D.C.Shown for the first time ever in the U.S., the pre-release of the Philips Xcelera 2.1 Cardiovascular Information Solution is one of the key components to Philips integrated catheterization (cath) lab, which includes physiomonitoring, reporting and cardiovascular X-ray technologies to improve patient care and lab management.
Multiple Sclerosis :: Multiple Sclerosis is not a terminal disease
At the MS Trust we strongly object to Multiple Sclerosis – MS being described as a terminal disease, as happened yet again yesterday in relation to the sad death of Gillian March. ‘Terminal’ is defined as “predicted to lead to death, especially slowly” (OED). We are all dying slowly but in fact the vast majority of people with MS will live fulfilling lives to an advanced age.
Breast Cancer :: Racial disparity in breast cancer outcome linked to aggressive tumors
Malignancies of the breast can be more aggressive and associated with poorer outcome in African-Americans than other races, according to a new study. Published in the December 1, 2006 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study reviewed patient data from two different clinical trial protocols – to control for healthcare access biases – and found that African-Americans have tumors with poorer prognostic cellular characteristics and more aggressive clinical presentations, pointing to the possibility that racially influenced tumor biology may contribute to observed racial disparities in breast cancer outcome.